Dawnrays Pharmaceutical (Holdings) Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 623.48 million compared to CNY 608.59 million a year ago. Net income was CNY 171.66 million compared to CNY 166.65 million a year ago.

Basic earnings per share from continuing operations was CNY 0.11456 compared to CNY 0.11127 a year ago. Diluted earnings per share from continuing operations was CNY 0.11429 compared to CNY 0.11085 a year ago.